Reimbursement stimulates South Korea's contrast media
This article was originally published in Clinica
Demand for radioactive contrast media in South Korea has been increasing rapidly since the inclusion of CT and MRI scans in the reimbursement system at the end of 1995. South Korea's contrast media market is expected to total around Won 150,000 million ($193 million) by the end of the decade, reports Pharma Koreana.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.